159 related articles for article (PubMed ID: 15864061)
1. Ultraporous beta-tricalcium phosphate is well incorporated in small cavitary defects.
Anker CJ; Holdridge SP; Baird B; Cohen H; Damron TA
Clin Orthop Relat Res; 2005 May; (434):251-7. PubMed ID: 15864061
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of ultraporous β-tricalcium phosphate (vitoss) as bone graft substitute for cavitary defects in benign and low-grade malignant bone tumors.
Van Hoff C; Samora JB; Griesser MJ; Crist MK; Scharschmidt TJ; Mayerson JL
Am J Orthop (Belle Mead NJ); 2012 Jan; 41(1):20-3. PubMed ID: 22389890
[TBL] [Abstract][Full Text] [Related]
3. Ultraporous β-tricalcium phosphate alone or combined with bone marrow aspirate for benign cavitary lesions: comparison in a prospective randomized clinical trial.
Damron TA; Lisle J; Craig T; Wade M; Silbert W; Cohen H
J Bone Joint Surg Am; 2013 Jan; 95(2):158-66. PubMed ID: 23324964
[TBL] [Abstract][Full Text] [Related]
4. The outcome of composite bone graft substitute used to treat cavitary bone defects.
Siegel HJ; Baird RC; Hall J; Lopez-Ben R; Lander PH
Orthopedics; 2008 Aug; 31(8):754. PubMed ID: 19292421
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcome of Beta-Tricalcium Phosphate Use for Bone Defects after Operative Treatment of Benign Tumors.
Chung H; Kim S; Chung SH
Clin Orthop Surg; 2019 Jun; 11(2):233-236. PubMed ID: 31156777
[TBL] [Abstract][Full Text] [Related]
6. Unexpected radiographic lucency following grafting of bone defects with calcium sulfate/tricalcium phosphate bone substitute.
Auston DA; Feibert M; Craig T; Damron TA
Skeletal Radiol; 2015 Oct; 44(10):1453-9. PubMed ID: 26081807
[TBL] [Abstract][Full Text] [Related]
7. Granular tricalcium phosphate grafting of cavitary lesions in human bone.
Nicholas RW; Lange TA
Clin Orthop Relat Res; 1994 Sep; (306):197-203. PubMed ID: 8070195
[TBL] [Abstract][Full Text] [Related]
8. Pediatric cranial vault defects: early experience with beta-tricalcium phosphate bone graft substitute.
Biskup NI; Singh DJ; Beals S; Joganic EF; Manwaring K
J Craniofac Surg; 2010 Mar; 21(2):358-62. PubMed ID: 20186087
[TBL] [Abstract][Full Text] [Related]
9. Comparative Study on the Application of Mesenchymal Stromal Cells Combined with Tricalcium Phosphate Scaffold into Femoral Bone Defects.
Šponer P; Kučera T; Brtková J; Urban K; Kočí Z; Měřička P; Bezrouk A; Konrádová Š; Filipová A; Filip S
Cell Transplant; 2018 Oct; 27(10):1459-1468. PubMed ID: 30203687
[TBL] [Abstract][Full Text] [Related]
10. Beta-tricalcium phosphate for orthopedic reconstructions as an alternative to autogenous bone graft.
Hernigou P; Dubory A; Pariat J; Potage D; Roubineau F; Jammal S; Flouzat Lachaniette CH
Morphologie; 2017 Sep; 101(334):173-179. PubMed ID: 28501353
[TBL] [Abstract][Full Text] [Related]
11. Bone healing and graft resorption of autograft, anorganic bovine bone and beta-tricalcium phosphate. A histologic and histomorphometric study in the mandibles of minipigs.
Jensen SS; Broggini N; Hjørting-Hansen E; Schenk R; Buser D
Clin Oral Implants Res; 2006 Jun; 17(3):237-43. PubMed ID: 16672017
[TBL] [Abstract][Full Text] [Related]
12. A prospective multicenter randomized clinical trial of autogenous bone versus beta-tricalcium phosphate graft alone for bilateral sinus elevation: histologic and histomorphometric evaluation.
Szabó G; Huys L; Coulthard P; Maiorana C; Garagiola U; Barabás J; Németh Z; Hrabák K; Suba Z
Int J Oral Maxillofac Implants; 2005; 20(3):371-81. PubMed ID: 15973948
[TBL] [Abstract][Full Text] [Related]
13. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up.
Dai LY; Jiang LS
Spine (Phila Pa 1976); 2008 May; 33(12):1299-304. PubMed ID: 18496340
[TBL] [Abstract][Full Text] [Related]
14. Beta-tricalcium phosphate and bone surgery: Editorial.
Chappard D
Morphologie; 2017 Sep; 101(334):111-112. PubMed ID: 28992852
[No Abstract] [Full Text] [Related]
15. Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts.
Zijderveld SA; Zerbo IR; van den Bergh JP; Schulten EA; ten Bruggenkate CM
Int J Oral Maxillofac Implants; 2005; 20(3):432-40. PubMed ID: 15973955
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive use of ultraporous beta-tricalcium phosphate bone void filler in spinal arthrodesis.
Meadows GR
Orthopedics; 2002 May; 25(5 Suppl):s579-84. PubMed ID: 12038845
[TBL] [Abstract][Full Text] [Related]
17. Use of an advanced formulation of beta-tricalcium phosphate as a bone extender in interbody lumbar fusion.
Linovitz RJ; Peppers TA
Orthopedics; 2002 May; 25(5 Suppl):s585-9. PubMed ID: 12038846
[TBL] [Abstract][Full Text] [Related]
18. Chronic infection and infected non-union of the long bones in paediatric patients: preliminary results of bone versus beta-tricalcium phosphate grafting after induced membrane formation.
Rousset M; Walle M; Cambou L; Mansour M; Samba A; Pereira B; Ghanem I; Canavese F
Int Orthop; 2018 Feb; 42(2):385-393. PubMed ID: 29184978
[TBL] [Abstract][Full Text] [Related]
19. Adverse reactions of artificial bone graft substitutes: lessons learned from using tricalcium phosphate geneX®.
Friesenbichler J; Maurer-Ertl W; Sadoghi P; Pirker-Fruehauf U; Bodo K; Leithner A
Clin Orthop Relat Res; 2014 Mar; 472(3):976-82. PubMed ID: 24078171
[TBL] [Abstract][Full Text] [Related]
20. A new β-tricalcium phosphate with uniform triple superporous structure as a filling material after curettage of bone tumor.
Seto S; Muramatsu K; Hashimoto T; Tominaga Y; Taguchi T
Anticancer Res; 2013 Nov; 33(11):5075-81. PubMed ID: 24222152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
